Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer

Shinichiro Kashiwagi; Yuka Asano; Wataru Goto; Koji Takada; Katsuyuki Takahashi; Satoru Noda; Tsutomu Takashima; Naoyoshi Onoda; Shuhei Tomita; Masahiko Ohsawa; Kosei Hirakawa; Masaichi Ohira

doi:10.1371/journal.pone.0170634

Loading metrics

Open Access

Peer-reviewed

Research Article

Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer

Shinichiro Kashiwagi ,

* E-mail: spqv9ke9@view.ocn.ne.jp

Affiliation Department of Surgical Oncology; Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Yuka Asano ,

Contributed equally to this work with: Yuka Asano, Masaichi Ohira

Affiliation Department of Surgical Oncology; Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Wataru Goto,

Affiliation Department of Surgical Oncology; Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Koji Takada,

Affiliation Department of Surgical Oncology; Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Katsuyuki Takahashi,

Affiliation Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Satoru Noda,

Affiliation Department of Surgical Oncology; Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Tsutomu Takashima,

Affiliation Department of Surgical Oncology; Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Naoyoshi Onoda,

Affiliation Department of Surgical Oncology; Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Shuhei Tomita,

Affiliation Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Masahiko Ohsawa,

Affiliation Department of Diagnostic Pathology; Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Kosei Hirakawa,

Affiliation Department of Surgical Oncology; Osaka City University Graduate School of Medicine, Osaka, Japan
⨯
Masaichi Ohira

Contributed equally to this work with: Yuka Asano, Masaichi Ohira

Affiliation Department of Surgical Oncology; Osaka City University Graduate School of Medicine, Osaka, Japan
⨯

Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer

Shinichiro Kashiwagi,
Yuka Asano,
Wataru Goto,
Koji Takada,
Katsuyuki Takahashi,
Satoru Noda,
Tsutomu Takashima,
Naoyoshi Onoda,
Shuhei Tomita,
Masahiko Ohsawa

Published: February 6, 2017
https://doi.org/10.1371/journal.pone.0170634

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Combination chemotherapy
Is the Subject Area "Combination chemotherapy" applicable to this article?

Thanks for your feedback.
Cancer immunotherapy
Is the Subject Area "Cancer immunotherapy" applicable to this article?

Thanks for your feedback.
Tumor-infiltrating lymphocytes
Is the Subject Area "Tumor-infiltrating lymphocytes" applicable to this article?

Thanks for your feedback.